A case of minimal uterine serous carcinoma with distant lymph node metastasis without peritoneal dissemination by Kawano, Kouichiro et al.
INTRODUCTION
Uterine serous adenocarcinoma (USC) accounts for less 
than 10% of endometrial cancers and is a highly aggressive 
tumor which often presents with extra-uterine spread [1]. 
Although recent studies show that serous endometrial 
intraepithelial carcinoma (EIC) is the precursor of USC, 
serous EIC demonstrates a stage-dependent potential for 
aggressive behavior similar to that of USC [2,3]. Therefore, 
surgical staging is recommended in the case of a USC, even 
though the intrauterine lesion is minimal. Wheeler et al. [2] 
proposed to define superficial serous carcinoma (SSC) as 
USC without myometrial and lymphovascular invasion, and 
serous EIC as minimal uterine serous carcinoma (minimal USC) 
because it is difficult to distinguish these two lesions based 
on identification of stromal invasion and clinical behavior. 
Among patterns of extra-uterine spread presented in 33% to 
45% of minimal USC [2,3], distant lymph node metastasis has 
not been previously reported. Therefore, we describe a case 
with minimal USC showing an unusual spread pattern, with 
cervical lymph node metastasis through the pelvic and para-
aortic lymph nodes.
CASE REPORT
A 61-year old woman (gravida 2, para 2) presented at the ob-
stetrics and gynecology clinic with postmenopausal vaginal 
bleeding. She was referred to our department because of 
positive endometrial cytology. Pelvic examination results 
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were poor due to obesity, with a body mass index of 35.0 kg/
m
2. Ultrasonography and magnetic resonance imaging of the 
pelvic organs revealed not increased endometrial thick  ness 
but rather, a small myoma. Endometrial curettage revealed 
a grade 1 endometrioid adenocarcinoma from the villo  glan-
dular proliferation of atypical cells (Fig. 1A). Colono  scopy and 
cystoscopy showed abnormal findings on the surface of the 
rectum and bladder, respectively. Chest and abdominal com-
puted tomography revealed no abnormality including the 
pelvic and para-aortic lymph nodes. Serum CA-125 levels were 
elevated to 41.8 U/mL.
Laparotomy was performed under the diagnosis of endo  me-
trial cancer. No macroscopic abnormalities were seen in the 
abdominal cavity, including the pelvic and para-aortic lymph 
nodes. Total abdominal hysterectomy, bilateral salpingo-
oophorectomy and biopsy of the external iliac lymph node was 
performed. Since the preoperative histopathological diagnosis 
was grade 1 endometrioid adenocarcinoma, and laparotomy 
revealed no swollen pelvic or para-aortic lymph nodes, 
dissection of these nodes was omitted. The endometrium 
was macroscopically atrophic in the extirpated uterus. 
Histopathological examination revealed no lesions in the 
uterus, but adenocarcinoma was present accompanied by 
psammoma body in the external iliac lymph node (Fig. 1B). 
Peritoneal washing cytology was negative. Based on pre- and 
postoperative histopathological findings, the final diagnosis 
was endometrial carcinoma stage IIIC (pT1aN1M0) according 
to the International Federation of Obstetrics and Gynecology 
(FIGO) classification. After surgery, 18-fluorodeoxyglucose 
positron emission tomography/computed tomography (PET/
CT) revealed left supraclavicular and para-aortic lymph node 
metastases. Therefore, we reviewed the specimen of the 
endometrial biopsy. The papillary part with prominent nuclear 
atypia in the villoglandular architecture was observed in the 
specimen (Fig. 1C). Immunohistochemical staining indicated 
the expression of p53 both in the papillary part of the biopsied 
Fig. 1. (A) The glandular pattern of proliferation in a small fragment 
was observed (H&E, x100). (B) Metastasized lymph node with 
adenocarcinoma accompanied by psamomma bodies (H&E, x200). (C) 
The papillary part with prominent nuclear atypia in the villo-glandular 
architecture was observed in the specimens obtained from D&C (H&E, 
x200).Minimal uterine serous carcinoma showing an unusual spread pattern
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endometrium (Fig. 2A) and the metastasized pelvic lymph 
node (Fig. 2B). Expression of estrogen receptor, progesterone 
receptor, and PTEN was not observed immunohistochemically 
(data not shown). Thus, the final histopathological diagnosis 
was an endometrial serous adenocarcinoma together with a 
metastatic lymph node.
This patient underwent 6 cycles of chemotherapy with a 
combination of cisplatin (50 mg/m
2) and doxorubicin (60 mg/
m
2). Additional external beam radiation therapy (Liniac 3 Gy 
×15) was given to the left supraclavicular region because 
the left supraclavicular lymph node remained swollen after 
chemotherapy. The patient maintained no evidence of disease 
37 months after operation. 
DISCUSSION
USC is uncommon, but accounts for a disproportionate 
number of endometrial cancer deaths. Hamilton et al. [4] 
reported that the poorer prognosis of USC and clear cell 
carcinoma might be due to advanced status at presentation, 
although both remain as independent prognostic factors 
for poor survival in multivariate analysis. USC is a highly 
aggressive carcinoma and shows different spread patterns 
from endometrioid adeno-carcinoma. Deep myometrial 
invasion is the strongest predictor of extrauterine spread 
of disease in endometrioid adenocarcinoma. On the other 
hand, the absence of myometrial invasion does not predict 
the absence of lymph node involvement or extrauterine 
metastasis in uterine papillary serous carcinoma [5]. Several 
studies revealed that 50% to 75% of clinical stage I USC 
was upstaged by surgical staging [6-8]. Even though the 
primary lesion in the endometrium was minimal, 33% to 
45% of USC spread outside the uterus [2,3]. In the present 
case, pelvic and para-aortic lymph node metastasis was 
observed without peritoneal dissemination. Furthermore, 
supraclavicular lymph node metastasis was detected by 
FDG-PET. This may be via the regional lymph nodes. These 
reports indicate that surgical staging is recommended even 
in cases of non-invasive endometrial cancer when serous 
adenocarcinoma is suspected. In our case, complete surgical 
staging was not undertaken because USC was not diagnosed 
preoperatively and no significant malignant lesion was 
identified macroscopically at surgery. Since USC mimics low 
grade endometrioid adenocarcinoma, USC is sometimes 
difficult to differentiate from low grade endometrioid 
adenocarcinoma histopathologically [9]. Wheeler et al. [2] 
reported that 5 of 21 cases of minimal USC were originally 
diagnosed as endometrioid adenocarcinoma. Most of them 
were reclassified as USC from their aggressive clinical behavior 
despite the minimal volume of the lesion in the uterus. Thus, 
most cases initially classified as endometrioid adenocarcinoma 
showed well-formed gland like structure and marked 
nuclear atypia. Furthermore, they mentioned that the histo-
pathological diagnosis of EIC and SSC may be challenging, 
especially in biopsies or curettages, because the lesions may 
be focal and small. Furthermore, recognizing the high nuclear 
grade in scant specimens, or suboptimally preserved material, 
can be problematic, leading to misdiagnosis. It was difficult 
to diagnose USC in our case for the same reasons described 
above. Immunohistochemical staining of p53 has been 
reported to be helpful in the diagnosis of USC [10], especially 
in distinguishing USC from architecturally well-differentiated 
tumors [9]. Regarding our case, the immunostaining of p53 
Fig. 2. Positive nuclear staining of p53 was observed in specimens obtained from D&C (x200) (A) and metastasized lymph node (x200) (B).Kouichiro Kawano, et al.
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was helpful in the diagnosis of minimal USC as well.
In conclusion, we experienced a case of minimal USC, with 
regional and distant lymph node metastases. It also showed 
an unusual spread pattern with distant metastasis despite a 
lack of intraperitoneal dissemination. USC must be suspected 
when encountering cases with extrauterine spread of disease, 
regardless of tumor size. Although it is challenging to make 
a diagnosis with curetted out specimen, with small fraction, 
tumor spreading pattern and immunohistochemical findings 
were helpful in making the final diagnosis.
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